Prevalence and odds of any skin cancer, melanoma, and psoriasis diagnosis higher compared with nonveterans

Low-dose metformin linked to symptomatic improvement and modulation of gene expression in study involving 12 Black women

Vitamin C, retinol, and carotene are not causally tied to atopic dermatitis

Of those seeking medical care for xylazine wounds, 74 percent reported health care stigma, 58 percent inadequate pain and withdrawal management

Most patients with BCC, SCC have residual tumor at time of MMS, including in some clinically appearing tumor-free after biopsy

Both platelet-rich plasma and tranexamic acid combined with microneedling improved melasma in split-face study

Weight gain may increase atopic dermatitis risk, while weight loss may lower the risk

Significant improvements seen in skin hydration, visual radiance and smoothness, and reduction in transepidermal water loss

Higher odds of skin cancer seen for rural non-Hispanic Whites, Blacks, Hispanics, other race non-Hispanics, and Asians

HS risk lower for smoking quitters, those who maintained cessation status, and never smokers versus sustained smokers

Upadacitinib outperforms dupilumab in achieving superior efficacy for atopic dermatitis

Postinflammatory hyperpigmentation seen more often versus lighter skin tones

Galderma’s nemolizumab is the first monoclonal antibody to specifically target IL-31 signaling

Clinical trials show significant benefits for itch, skin nodules, and sleep disturbance versus placebo

Findings show decrease in survival from three years of treatment to five years for patients treated with ICIs in clinical practice

80 percent of patients with withdrawal of treatment lose benefit; most recapture benefit after retreatment

Gene expression signature predicts irAEs in melanoma patients treated with ipilimumab/nivolumab

23.8 percent of patients discontinued dupilumab, with adverse events and ineffectiveness the most common reasons

Skin biopsies, indicating diagnostic uncertainty, performed most frequently for Black patients

Extending the interval to 16 weeks from eight weeks is noninferior for patients with moderate-to-severe psoriasis

Seven patients received more than one excision; one of these tumors was recurrent lentigo maligna

Higher risk for incident comorbidities also seen compared with matched controls without alopecia